ReviewMaternal health, neonatology and perinatology2025
Determinants of non-adherence to antiretroviral therapy among seropositive pregnant women at public health facilities in Dessie Town, Ethiopia, 2024.
Review in Maternal health, neonatology and perinatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-adherence to antiretroviral therapy (ART) among pregnant women poses significant challenges to effective Immunodeficiency Virus (HIV) treatment outcomes and the promotion of maternal and infant health. This study identifies factors influencing ART non-adherence among HIV-positive pregnant women attending public health facilities in Dessie Town, Ethiopia.
methodsA facility-based case-control study was conducted with 278 participants across health institutions in Dessie Town, comprising 208 controls and 70 cases. Non-adherence to ART was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8. Data were collected through structured interviewer-administered questionnaires and by reviewing patients' medical records using pretested instruments. The collected data were coded and entered into EpiData version 4.6, then analyzed using SPSS version 25. Variables with a P-value of 0.2 in Bivariable analysis were included in a multivariable regression model, and Adjusted Odds Ratios (AOR) with 95% confidence intervals (CI) were calculated. P-values less than 0.05 were considered statistically significant.
resultsIn total, 208 controls and 70 cases were included in the study. Significant factors determining non-adherence to ART among HIV-positive pregnant women included forgetfulness to take ART (AOR = 2.414, 95% CI = 1.067-5.464, P = 0.034), non-disclosure (AOR = 2.955, 95% CI = 1.431-6.103, P = 0.003), an unplanned pregnancy (AOR = 3.045, 95% CI = 1.439-6.445, P = 0.004), those who did not participate in mother-support groups (AOR = 3.278, 95% CI = 1.611-6.672, P = 0.001), World Health Organization (WHO) clinical stages III & IV (AOR = 2.669, 95% CI = 1.279-5.569, P = 0.009), and those who did not take opportunistic infection prophylaxis (AOR = 3.873, 95% CI = 1.549-9.688, P = 0.004).
conclusionsKey determinants included forgetfulness, non-disclosure of HIV status, unplanned pregnancies, lack of participation in mother-support groups, advanced WHO clinical stages (III & IV), and non-use of opportunistic infection prophylaxis. RECOMMENDATIONS: All relevant parties, including front-line healthcare professionals, should advise women to use family planning more frequently to reduce unintended pregnancies. They should also encourage health education regarding disclosing HIV status to her spouse and ensure that all pregnant women are provided with opportunistic infection prophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.